GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 69 filers reported holding GENERATION BIO CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,541,006 | +18.6% | 406,598 | +72.1% | 0.00% | +100.0% |
| Q2 2023 | $1,299,403 | +30.6% | 236,255 | +2.1% | 0.00% | 0.0% |
| Q1 2023 | $995,282 | +9.4% | 231,461 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $909,642 | -22.8% | 231,461 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,178,000 | -14.5% | 231,461 | +10.2% | 0.00% | -50.0% |
| Q2 2022 | $1,377,000 | -10.6% | 209,961 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $1,541,000 | -8.4% | 209,961 | -11.6% | 0.00% | 0.0% |
| Q4 2021 | $1,682,000 | -64.6% | 237,621 | +25.5% | 0.00% | -80.0% |
| Q3 2021 | $4,747,000 | +22.7% | 189,340 | +6.4% | 0.01% | +25.0% |
| Q2 2021 | $3,868,000 | -13.7% | 177,915 | +13.0% | 0.00% | -20.0% |
| Q1 2021 | $4,481,000 | +46.5% | 157,441 | +45.9% | 0.01% | +25.0% |
| Q4 2020 | $3,058,000 | +283.2% | 107,881 | +317.9% | 0.00% | +300.0% |
| Q3 2020 | $798,000 | +61.5% | 25,818 | +9.8% | 0.00% | 0.0% |
| Q2 2020 | $494,000 | – | 23,518 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |